Investigating the effect of chest physiotherapy in the treatment of covid-19

The effect of chest physiotherapy on the clinical outcomes of patients with COVID 19

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220815055703N1

Enrollment

Registered

2022-11-15

Start date

2022-10-07

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Investigating the effect of chest physiotherapy on the recovery of patients with covid-19. COVID-19, virus identified

Interventions

Intervention 1: Intervention group: Patients in the intervention group will undergo chest physiotherapy in addition to routine care related to the care of patients with covid-19. Chest physiotherapy i

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Desire to participate in the study The average severity of the disease based on the diagnosis of a doctor specializing in respiratory diseases Hospitalization at the time of diagnosis Not using other chest physiotherapy programs at the same time Absence of underlying diseases such as cancer, cardiovascular diseases and diabetes Patient alertness Able to perform chest physiotherapy activities

Exclusion criteria

Exclusion criteria: Reluctance or refusal to participate in the study Changing the level of severity of the disease from moderate to severe level of the disease Having respiratory failure

Design outcomes

Primary

Measure	Time frame
Vital capacity (FEV2/FVC ratio). Timepoint: Before starting the intervention and at the end of the sixth day after the start of the intervention (physiotherapy). Method of measurement: Spirometry device.;Arterial blood gases include: (PaO2), (PaCO2), (SaO2), (PaO2/FiO2). Timepoint: Before starting the intervention and at the end of the sixth day after the start of the intervention (physiotherapy). Method of measurement: Arterial blood test.	—

Measure

Time frame

Vital capacity (FEV2/FVC ratio). Timepoint: Before starting the intervention and at the end of the sixth day after the start of the intervention (physiotherapy). Method of measurement: Spirometry device.;Arterial blood gases include: (PaO2), (PaCO2), (SaO2), (PaO2/FiO2). Timepoint: Before starting the intervention and at the end of the sixth day after the start of the intervention (physiotherapy). Method of measurement: Arterial blood test.

—

Secondary

Measure	Time frame
Vital capacity Vital capacity (FEV2/FVC ratio). Timepoint: At the end of the third and sixth days after the intervention (physiotherapy). Method of measurement: Spirometry device.;Arterial blood gases include: (PaO2), (PaCO2), (SaO2), (PaO2/FiO2). Timepoint: At the end of the sixth day after the start of the intervention (physiotherapy). Method of measurement: Arterial blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Moradi Azgil

Ahvaz University of Medical Sciences

rezanurs73@gmail.com+98 61 4363 1059

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026